Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Update

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the target of a significant decline in short interest in the month of December. As of December 31st, there was short interest totalling 43,600 shares, a decline of 62.4% from the December 15th total of 116,100 shares. Currently, 3.2% of the shares of the stock are sold short. Based on an average trading volume of 1,160,000 shares, the days-to-cover ratio is currently 0.0 days.

Arcadia Biosciences Stock Up 1.0 %

Shares of RKDA stock traded up $0.05 during trading on Tuesday, reaching $4.90. 5,647 shares of the company’s stock were exchanged, compared to its average volume of 25,206. Arcadia Biosciences has a twelve month low of $1.85 and a twelve month high of $10.31. The firm’s fifty day moving average price is $4.72 and its 200-day moving average price is $3.63. The stock has a market capitalization of $6.69 million, a PE ratio of -1.14 and a beta of 0.90.

Wall Street Analysts Forecast Growth

Separately, StockNews.com started coverage on shares of Arcadia Biosciences in a report on Friday. They issued a “sell” rating on the stock.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.